Skip to main content
Top
Published in: Rheumatology International 8/2015

01-08-2015 | Original Article - Imaging

Ultrasonographic measurement of carotid artery resistive index and diastolic function of the heart in gout patients

Authors: Rada N. Gancheva, Atanas I. Kundurdjiev, Mariana G. Ivanova, Todor G. Kundurzhiev, Rasho K. Rashkov, Zlatimir G. Kolarov

Published in: Rheumatology International | Issue 8/2015

Login to get access

Abstract

The aim of the study was to establish the functional disorder in the blood circulation of gout patients with a method that shows early damage of the heart and vascular structures. A total of 117 patients were examined cross-sectionally by a complex multimodal ultrasonography and were divided into four groups: 37 healthy controls, 24 asymptomatic hyperuricemia, 36 gout without tophi and 20 gouty tophi. With pulsed Doppler, common carotid artery resistive index (CCARI) and parameters of the transmitral blood flow were determined: the ratio between maximal early and late flow velocities (E/A ratio) and deceleration time (DT). With tissue Doppler imaging, mitral annular peak velocity (Em) was obtained. In the examined ultrasonographic parameters between healthy controls and the three patient groups, there was a statistically significant difference (p < 0.001). Comparing asymptomatic hyperuricemia and gout without tophi, no significant difference in CCARI (p = 0.656), E/A ratio (p = 0.472), DT (p = 0.990) and Em (p = 0.488) was found. Gouty tophi in comparison with gout without tophi and asymptomatic hyperuricemia had significantly lower Em (mean ± SD 0.07 ± 0.02 vs 0.09 ± 0.03 vs 0.13 ± 0.17) and significantly higher CCARI (mean ± SD 0.74 ± 0.05 vs 0.70 ± 0.05 vs 0.69 ± 0.05). Further multiple logistic regression revealed that tophi increased subject’s likelihood of having category of CCARI ≥ 0.7 with an OR = 10.91 (95 % CI 1.80–66.14, p = 0.009), while the category of Em < 0.08 m/s was influenced by renal insufficiency with an OR = 3.07 (95 % CI 1.17–8.02, p = 0.022). Gouty tophi are associated with progression of arteriosclerotic-type vessel changes. Worsening of diastolic dysfunction of the heart is independently associated with renal insufficiency. In terms of CV risk, tophi are an indicator of its increase.
Literature
1.
go back to reference Choi HK, Curhan G (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation 116:894–900PubMedCrossRef Choi HK, Curhan G (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation 116:894–900PubMedCrossRef
3.
go back to reference Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH (1966) Hyperuricemia in primary and renal hypertension. N Engl J Med 275:457–464PubMedCrossRef Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH (1966) Hyperuricemia in primary and renal hypertension. N Engl J Med 275:457–464PubMedCrossRef
4.
go back to reference Tuttle KR, Short RA, Johnson RJ (2001) Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 87:1411–1414PubMedCrossRef Tuttle KR, Short RA, Johnson RJ (2001) Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 87:1411–1414PubMedCrossRef
5.
go back to reference Lehto S, Niskanen L, Ronnemaa T, Laakso M (1998) Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29:635–639PubMedCrossRef Lehto S, Niskanen L, Ronnemaa T, Laakso M (1998) Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29:635–639PubMedCrossRef
6.
go back to reference Siu YP, Leung KT, Tong MK, Kwan TH (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47:51–59PubMedCrossRef Siu YP, Leung KT, Tong MK, Kwan TH (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47:51–59PubMedCrossRef
7.
go back to reference Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7–13PubMedCrossRef Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7–13PubMedCrossRef
8.
go back to reference Cooney MT, Dudina A, D’Agostino R, Graham IM (2010) Cardiovascular risk-estimation systems in primary prevention do they differ? Do they make a difference? Can we see the future? Circulation 122:300–310PubMedCrossRef Cooney MT, Dudina A, D’Agostino R, Graham IM (2010) Cardiovascular risk-estimation systems in primary prevention do they differ? Do they make a difference? Can we see the future? Circulation 122:300–310PubMedCrossRef
9.
go back to reference Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, Backer GD, Baquer DD et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003PubMedCrossRef Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, Backer GD, Baquer DD et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003PubMedCrossRef
10.
go back to reference Build DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR et al (2002) Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156:871–881CrossRef Build DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR et al (2002) Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156:871–881CrossRef
11.
go back to reference Naqhavi M, Falk E, Hecht HS, Shah PK, Task Force SHAPE (2006) The first SHAPE (screening for heart attack Prevention and education) guideline. Crit Pathw Cardiol 5(4):187–190CrossRef Naqhavi M, Falk E, Hecht HS, Shah PK, Task Force SHAPE (2006) The first SHAPE (screening for heart attack Prevention and education) guideline. Crit Pathw Cardiol 5(4):187–190CrossRef
12.
go back to reference González-Gay MA, González-Juanatey C, llorca J (2012) Carotid Ultrasound in the cardiovascular risk stratification of patients with rheumatoid arthritis. Ann Rheum Dis 71(6):796–798PubMedCrossRef González-Gay MA, González-Juanatey C, llorca J (2012) Carotid Ultrasound in the cardiovascular risk stratification of patients with rheumatoid arthritis. Ann Rheum Dis 71(6):796–798PubMedCrossRef
14.
go back to reference Staub D, Meyerhans A, Bundi B, Schmid HP, Frauchiger B (2006) Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke 37:800–805PubMedCrossRef Staub D, Meyerhans A, Bundi B, Schmid HP, Frauchiger B (2006) Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke 37:800–805PubMedCrossRef
15.
go back to reference Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20(3):895–900PubMedCrossRef Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20(3):895–900PubMedCrossRef
16.
go back to reference Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J et al (1996) Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am SocEchocardiogr 9:736–760CrossRef Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J et al (1996) Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am SocEchocardiogr 9:736–760CrossRef
17.
go back to reference Ho CY, Solomon SD (2006) A clinician’s guide to tissue Doppler imaging. Circulation 113:396–398CrossRef Ho CY, Solomon SD (2006) A clinician’s guide to tissue Doppler imaging. Circulation 113:396–398CrossRef
18.
go back to reference Frauchinger B, Schmid HP, Roedel C, Moosmann P, Staub D (2001) Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke 32:836–841CrossRef Frauchinger B, Schmid HP, Roedel C, Moosmann P, Staub D (2001) Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke 32:836–841CrossRef
19.
go back to reference Palmieri V, Arezzi E, Sabatella M, Celentano A (2003) Interstudy reproducibility of parameters of left ventricular diastolic function: a Doppler echocardiography study. J Am Soc Echocardiogr 16(11):1128–1135PubMedCrossRef Palmieri V, Arezzi E, Sabatella M, Celentano A (2003) Interstudy reproducibility of parameters of left ventricular diastolic function: a Doppler echocardiography study. J Am Soc Echocardiogr 16(11):1128–1135PubMedCrossRef
20.
go back to reference Nagueh SF, Middleton KJ, Kopelan HA, Zoghbi WA, Quiñones MA (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533PubMedCrossRef Nagueh SF, Middleton KJ, Kopelan HA, Zoghbi WA, Quiñones MA (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533PubMedCrossRef
21.
go back to reference Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA et al (2004) Changes in arterial stiffness and wave reflections with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 43:1239–1245PubMedCrossRef Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA et al (2004) Changes in arterial stiffness and wave reflections with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 43:1239–1245PubMedCrossRef
22.
go back to reference Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM (2005) Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension 45:592–596PubMedCrossRef Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM (2005) Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension 45:592–596PubMedCrossRef
23.
go back to reference Avolio AO, Chen SG, Wang RP, Zhang CL, Li MF, O’Rourke MF (1983) Effects of aging on changing arterial compliance and left ventricular load in a Northern Chinese urban community. Circulation 68:50–58PubMedCrossRef Avolio AO, Chen SG, Wang RP, Zhang CL, Li MF, O’Rourke MF (1983) Effects of aging on changing arterial compliance and left ventricular load in a Northern Chinese urban community. Circulation 68:50–58PubMedCrossRef
24.
go back to reference London G, Covic A, Goldsmith D, Wiecek A, Suleymanlar G, Ortiz A (2011) Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow-implications for CKD and cardiovascular disease. Kidney Int Suppl 1:10–12CrossRef London G, Covic A, Goldsmith D, Wiecek A, Suleymanlar G, Ortiz A (2011) Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow-implications for CKD and cardiovascular disease. Kidney Int Suppl 1:10–12CrossRef
25.
go back to reference Cipolli JA, Ferreira-Sae MC, Martins RP, Pio-Magalhães JA, Bellinazzi VR, Matos-Souza JR et al (2012) Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study. BMC Cardiovasc Disord 12:52. doi:10.1186/1471-2261-12-52 PubMedCentralPubMedCrossRef Cipolli JA, Ferreira-Sae MC, Martins RP, Pio-Magalhães JA, Bellinazzi VR, Matos-Souza JR et al (2012) Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study. BMC Cardiovasc Disord 12:52. doi:10.​1186/​1471-2261-12-52 PubMedCentralPubMedCrossRef
26.
go back to reference Pan KL, Lin JC, Lin CL, Chen MC, Chang PJ, Hsiao JF et al (2014) The effects of gout on left atrial volume remodeling: a prospective echocardiographic study. Rheumatology (Oxford) 53(5):867–874. doi:10.1093/rheumatology/ket444 CrossRef Pan KL, Lin JC, Lin CL, Chen MC, Chang PJ, Hsiao JF et al (2014) The effects of gout on left atrial volume remodeling: a prospective echocardiographic study. Rheumatology (Oxford) 53(5):867–874. doi:10.​1093/​rheumatology/​ket444 CrossRef
27.
go back to reference Smielewski P, Czosnyka M, Kirkpatrick P, McEroy H, Rutkowska H, Pickard JD (1996) Assessment of cerebral autoregulation using carotid artery compression. Stroke 27:2197–2203PubMedCrossRef Smielewski P, Czosnyka M, Kirkpatrick P, McEroy H, Rutkowska H, Pickard JD (1996) Assessment of cerebral autoregulation using carotid artery compression. Stroke 27:2197–2203PubMedCrossRef
28.
go back to reference Kim MK, Kim B, Lee JY, Kim JS, Han BG, Choi SO et al (2013) Tissue Doppler-derived E/e’ ratio as a parameter for assessing diastolic heart failure and as a predictor of mortality in patients with chronic kidney disease. Korean J Intern Med 28(1):35–44PubMedCentralPubMedCrossRef Kim MK, Kim B, Lee JY, Kim JS, Han BG, Choi SO et al (2013) Tissue Doppler-derived E/e’ ratio as a parameter for assessing diastolic heart failure and as a predictor of mortality in patients with chronic kidney disease. Korean J Intern Med 28(1):35–44PubMedCentralPubMedCrossRef
29.
go back to reference Roch-Ramel F, Guisan B (1999) Renal transport of urate in humans. News Physiol Sci 14:80–84PubMed Roch-Ramel F, Guisan B (1999) Renal transport of urate in humans. News Physiol Sci 14:80–84PubMed
32.
go back to reference Bordoni V, de Cal M, Rassu M, Cazzavillan S, Segala C, Bonello M (2005) Protective effect of urate oxidase on uric acid induced-monocyte apoptosis. Curr Drug Discov Technol 2(1):29–36PubMedCrossRef Bordoni V, de Cal M, Rassu M, Cazzavillan S, Segala C, Bonello M (2005) Protective effect of urate oxidase on uric acid induced-monocyte apoptosis. Curr Drug Discov Technol 2(1):29–36PubMedCrossRef
33.
go back to reference Schumacher HR Jr (2008) The pathogenesis of gout. Clevel Clin J Med 75(5):2–4CrossRef Schumacher HR Jr (2008) The pathogenesis of gout. Clevel Clin J Med 75(5):2–4CrossRef
34.
go back to reference Carter JD, Keder RP, Anderson SR, Osorio AH, Albritton NL, Gnanashanmugam S et al (2009) An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs. Rheumatology 48:1442–1446PubMedCrossRef Carter JD, Keder RP, Anderson SR, Osorio AH, Albritton NL, Gnanashanmugam S et al (2009) An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs. Rheumatology 48:1442–1446PubMedCrossRef
Metadata
Title
Ultrasonographic measurement of carotid artery resistive index and diastolic function of the heart in gout patients
Authors
Rada N. Gancheva
Atanas I. Kundurdjiev
Mariana G. Ivanova
Todor G. Kundurzhiev
Rasho K. Rashkov
Zlatimir G. Kolarov
Publication date
01-08-2015
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2015
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-015-3280-7

Other articles of this Issue 8/2015

Rheumatology International 8/2015 Go to the issue

Letter to the Editor - Food for Thought

Meat consumption and gout: Friend, foe or neither?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine